I agree that this site is using cookies. You can find further informations here.
X
Chui, M. Herman
~ 1000  results:
Search for persons X
?
1

A phase 2 trial of zanidatamab in HER2-overexpressed advanc..:

Lumish, Melissa ; Chui, M. Herman ; Zhou, Qin...
Gynecologic Oncology.  182 (2024)  - p. 75-81 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Molecular profiling of primary endometrioid endometrial can..:

Gordhandas, Sushmita ; Da Cruz Paula, Arnaud ; Kertowidjojo, Elizabeth C....
Gynecologic Oncology Reports.  53 (2024)  - p. 101391 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Folate receptor alpha expression in low-grade serous ovaria..:

Manning-Geist, Beryl L. ; Sullivan, Mackenzie W. ; Zhou, Qin...
Gynecologic Oncology.  188 (2024)  - p. 52-57 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Morphologic and Molecular Heterogeneity of High-grade Serou..:

Chien, Yen-Wei ; Wang, Yeh ; Huang, Peng...
American Journal of Surgical Pathology.  48 (2024)  4 - p. 475-486 , 2024
Link: https://doi.org/10.1097/..
 
?
5

HER2 Genetic Intratumor Heterogeneity Is Associated With Re..:

Shen, Sherry ; Ma, Weining ; Brown, David...
Modern Pathology.  36 (2023)  11 - p. 100299 , 2023
Link: https://doi.org/10.1016/..
 
?
6

The highs and lows of serous ovarian cancer:

Grisham, Rachel N. ; Manning‐Geist, Beryl L. ; Chui, M. Herman
Cancer.  129 (2023)  17 - p. 2613-2620 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Beyond the estrogen receptor: In search of predictive bioma..:

Grisham, Rachel N. ; Manning‐Geist, Beryl L. ; Chui, M. Herman
Cancer.  129 (2023)  9 - p. 1305-1307 , 2023
Link: https://doi.org/10.1002/..
 
?
8

Deep Interactive Learning-based ovarian cancer segmentation..:

Ho, David Joon ; Chui, M. Herman ; Vanderbilt, Chad M....
Journal of Pathology Informatics.  14 (2023)  - p. 100160 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Decreased HER2 expression in endometrial cancer following a..:

Chui, M Herman ; Brown, David N ; Da Cruz Paula, Arnaud...
The Journal of Pathology.  262 (2023)  2 - p. 129-136 , 2023
Link: https://doi.org/10.1002/..
 
?
10

Chemotherapy response in low‐grade serous ovarian carcinoma..:

Manning‐Geist, Beryl L. ; Kahn, Ryan M. ; Nemirovsky, David...
Cancer.  129 (2023)  13 - p. 2004-2012 , 2023
Link: https://doi.org/10.1002/..
 
?
11

Advancements in Low-Grade Serous Carcinoma of the Ovary and..:

Grisham, Rachel N. ; Chui, M. Herman
Current Oncology Reports.  24 (2022)  11 - p. 1549-1555 , 2022
Link: https://doi.org/10.1007/..
 
?
12

Histopathologic features and molecular genetic landscape of..:

Ross, Dara S. ; Devereaux, Kelly A. ; Jin, Cao...
Modern Pathology.  35 (2022)  7 - p. 962-971 , 2022
Link: https://doi.org/10.1038/..
 
?
13

Pre-clinical activity of the oral DNA-PK inhibitor, peposer..:

Gordhandas, Sushmita B. ; Manning-Geist, Beryl ; Henson, Christina...
Scientific Reports.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
14

Mullerian adenosarcoma: clinicopathologic and molecular cha..:

Momeni Boroujeni, Amir ; Kertowidjojo, Elizabeth ; Wu, Xinyu...
Modern Pathology.  35 (2022)  11 - p. 1684-1694 , 2022
Link: https://doi.org/10.1038/..
 
?
15

Characterization of TP53-wildtype tubo-ovarian high-grade s..:

Chui, M. Herman ; Momeni Boroujeni, Amir ; Mandelker, Diana..
Modern Pathology.  34 (2021)  2 - p. 490-501 , 2021
Link: https://doi.org/10.1038/..
 
1-15